TIR-Domain-Containing Adaptor-Inducing Interferon-β (TRIF) Mediates Antibacterial Defense during Gram-Negative Pneumonia by Inducing Interferon-γ
暂无分享,去创建一个
[1] M. Netea,et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series , 2014, BMC Infectious Diseases.
[2] O. Pappo,et al. Bone Marrow and Nonbone Marrow Toll Like Receptor 4 Regulate Acute Hepatic Injury Induced by Endotoxemia , 2013, PloS one.
[3] M. Falagas,et al. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. , 2012, The Journal of antimicrobial chemotherapy.
[4] T. van der Poll,et al. Differential roles of MyD88 and TRIF in hematopoietic and resident cells during murine gram-negative pneumonia. , 2012, The Journal of infectious diseases.
[5] T. van der Poll,et al. Myeloid-Related Protein-14 Contributes to Protective Immunity in Gram-Negative Pneumonia Derived Sepsis , 2012, PLoS pathogens.
[6] J. Li,et al. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] T. van der Poll,et al. Delineation of the Role of Toll-like Receptor Signaling during Peritonitis by a Gradually Growing Pathogenic Escherichia coli , 2011, The Journal of Biological Chemistry.
[8] S. Akira,et al. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. , 2011, Immunity.
[9] F. Aversa,et al. Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO , 2010, Cellular and Molecular Immunology.
[10] T. van der Poll,et al. Host defence during Klebsiella pneumonia relies on haematopoietic-expressed Toll-like receptors 4 and 2 , 2010, European Respiratory Journal.
[11] T. Tsujimoto,et al. Salvage effect of E5564, Toll‐like receptor 4 antagonist on d‐galactosamine and lipopolysaccharide‐induced acute liver failure in rats , 2010, Journal of gastroenterology and hepatology.
[12] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[13] S. Batra,et al. Both TRIF- and MyD88-Dependent Signaling Contribute to Host Defense against Pulmonary Klebsiella Infection1 , 2009, The Journal of Immunology.
[14] M. Eisenhut. Acute lower respiratory tract infection. , 2008, The New England journal of medicine.
[15] L. González-Méndez,et al. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study , 2008, BMC infectious diseases.
[16] Y. Carmeli,et al. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.
[17] S. Akira,et al. References Subscriptions Permissions Email Alerts TLR9 Is Required for Protective Innate Immunity in Gram-Negative Bacterial Pneumonia: Role of Dendritic Cells , 2013 .
[18] D. Aronoff,et al. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. , 2007, American journal of respiratory cell and molecular biology.
[19] P. Carmeliet,et al. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. , 2007, Blood.
[20] J. Reiser,et al. Conditional expression of interferon-gamma to enhance host responses to pulmonary bacterial infection. , 2006, Pulmonary pharmacology & therapeutics.
[21] Marin H Kollef,et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.
[22] K. Schroder,et al. Interferon‐γ: an overview of signals, mechanisms and functions , 2004 .
[23] T. Standiford,et al. Anti-Tumor Necrosis Factor-&agr; Therapy During Murine Klebsiella pneumoniae Bacteremia: Increased Mortality in the Absence of Liver Injury , 2003, Shock.
[24] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[25] T. Standiford,et al. Divergent Role of Gamma Interferon in a Murine Model of Pulmonary versus Systemic Klebsiella pneumoniae Infection , 2002, Infection and Immunity.
[26] Y. Iwakura,et al. Role of interferon-gamma in inflammatory responses in murine respiratory infection with Legionella pneumophila. , 2002, Journal of medical microbiology.
[27] Y. Iwakura,et al. Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines. , 2001, Journal of medical microbiology.
[28] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[29] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[30] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[31] J. Shellito,et al. Adenoviral-mediated interferon-gamma gene therapy augments pulmonary host defense of ethanol-treated rats. , 1998, Alcoholism, clinical and experimental research.
[32] Murray Hw. Interferon-gamma in infection and immunoparalysis. , 1996 .
[33] H. D. Liggitt,et al. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon , 1991, Infection and immunity.
[34] R. D. Beer,et al. Cell-specific pattern recognition receptor signaling in antibacterial defense , 2015 .
[35] R. Reljic,et al. Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. , 2009, Tuberculosis.
[36] R. Wunderink,et al. Adjunctive Therapy in Community-Acquired Pneumonia , 2009, Seminars in respiratory and critical care medicine.
[37] A. Haque,et al. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. , 2007, The Journal of infectious diseases.
[38] H. Murray. Interferon-gamma in infection and immunoparalysis , 2005, Intensive Care Medicine.
[39] K. Schroder,et al. Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.